Raymund L Yong, MD Email Raymund Yong
-
- Positions
- ASSISTANT PROFESSOR | Neurosurgery
- ASSISTANT PROFESSOR | Oncological Sciences
-
- Specialty
- Neurosurgery
-
- Language
- English
-
- Hospital Affiliations
- Mount Sinai St. Luke's and Mount Sinai West
- The Mount Sinai Hospital
- Mount Sinai Queens
- Mount Sinai Beth Israel
-
- Phone
- Mount Sinai Doctors 212-241-5493 212-241-5493
- Mount Sinai Doctors Faculty Practice 212-241-5493 212-241-5493
Book an Appointment - Raymund L Yong, MD
Raymund Yong, MD, specializes in the diagnosis and treatment of malignant and benign brain tumors, and he also has an interest in general disorders of the brain and spine. He has subspecialty fellowship training in the removal of infiltrative tumors from eloquent regions of the brain—including the areas for language and motor function—using computer-guided navigation, brain mapping techniques, and awake surgery. Dr. Yong also has a strong research interest in using new insights on how gliomas originate and evolve through time to develop innovative treatment strategies for his patients. He has received several national and international awards for his work in stem cells and cancer genetics. He also collaborates with other investigators and institutions to enroll patients in clinical trials studying the latest experimental treatments.
Dr. Yong’s laboratory is interested in characterizing the initial genetic and epigenetic events that give rise to malignant brain tumors. Additionally, the lab seeks to understand how current standard treatment regimes, such as radiation therapy and chemotherapy, interact with the cancer genome to influence the way in which tumor cells change through time and diversify in different compartments in the brain. The inherent genetic instability of cancer cells and their resulting adaptive abilities is a major reason why gliomas inevitably recur following treatment and are ultimately fatal. A greater understanding of the cancer genome as a dynamic, three-dimensional structure will lead to the development of new strategies that attempt to address cancer evolution directly.
Read about Dr. Yong's patient who went "Back to Bowling from Brain Surgery."
Clinical Focus
- Acoustic Neuroma
- Acoustic Neuroma Removal
- Acromegaly
- Aphasia
- Astrocytoma
- Back Pain
- Benign Neoplasm
- Biopsy
- Bone Cancer
- Bone Hemangioma
- Brain / Spinal Cord Cancer
- Brain Cyst
- Brain Hemorrhage
- Brain Infection
- Brain Malformation
- Brain Metastasis
- Brain Scan
- Brain Surgery
- Brain Trauma / Injury
- Brain Tumor And Brain Cancer
- Brain, Spine Tumors
- Carpal Tunnel Release
- Carpal Tunnel Syndrome
- Cavernous Malformations
- Cervical Radiculopathy
- Chiari Malformation
- Chronic Neck Pain
- Craniopharyngioma
- Craniotomy
- Degenerative Disc Disease
- Disc Disease of Neck and Back
- Facial Pain
- Glioblastoma Multiforme
- Growth Hormone Testing
- Headache
- Herniated Disk
- Hydrocephalus
- Intracranial Abscess
- Laminectomy
- Leg Pain
- MRI - Spinal Cord
- Meningioma
- Neck Pain
- Neurofibromatosis
- Peripheral Neuropathy
- Pituitary Adenoma
- Pituitary Macroadenomas
- Sciatica
- Skull Base Surgery
- Skull Fracture
- Spinal Cord Disorder
- Spinal Cord Minimally Invasive Surgery
- Spinal Cord Second Opinion
- Spinal Cord Surgery
- Spinal Stenosis
- Spine Pain
- Subarachnoid Hemorrhage
- Subdural Hematoma
- Suprasellar Tumor
- Syrinx
- Tethered Cord Syndrome
- Traumatic Brain Injury
- Von Hippel-Lindau Disease
Education
MD, University of Calgary
Residency, Neurosurgery
University of British Columbia
Fellowship, Surgical Neurology
National Institute of Neurological Disorders and Stroke
Language
English
2012
Young Investigator Award
American Brain Tumor Association
For demonstrated outstanding potential for future basic science research
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Dr.Yong did not report having any of the following types of financial relationships with industry during 2018 and/or 2019: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website.
Patients may wish to ask their physician about the activities they perform for companies.
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.